<unk>  is indicated for the treatment of seizures associated with Dravet syndrome in people age two and older. Dravet syndrome is a life-threatening, rare and chronic form of epilepsy. It is often characterized by severe and unrelenting seizures despite medical treatment.
Fenfluramine
Benzoctamine
Tesofensine
Bremazocine
Dezocine
Clorotepine
Bethanechol
Ephedrine